Literature DB >> 35294873

Methylene-bridge tryptophan fatty acylation regulates PI3K-AKT signaling and glucose uptake.

Song-Hua Hu1, Xia-Di He1, Ji Nie1, Jun-Li Hou2, Jiang Wu3, Xiao-Yan Liu4, Yun Wei1, Hui-Ru Tang5, Wen-Xing Sun1, Shu-Xian Zhou1, Yi-Yuan Yuan1, Yan-Peng An5, Guo-Quan Yan5, Yan Lin1, Peng-Cheng Lin6, Jean J Zhao7, Ming-Liang Ye8, Jian-Yuan Zhao9, Wei Xu10, Shi-Min Zhao11.   

Abstract

Protein fatty acylation regulates numerous cell signaling pathways. Polyunsaturated fatty acids (PUFAs) exert a plethora of physiological effects, including cell signaling regulation, with underlying mechanisms to be fully understood. Herein, we report that docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) regulate PI3K-AKT signaling by modifying PDK1 and AKT2. DHA-administered mice exhibit altered phosphorylation of proteins in signaling pathways. Methylene bridge-containing DHA/EPA acylate δ1 carbon of tryptophan 448/543 in PDK1 and tryptophan 414 in AKT2 via free radical pathway, recruit both the proteins to the cytoplasmic membrane, and activate PI3K signaling and glucose uptake in a tryptophan acylation-dependent but insulin-independent manner in cultured cells and in mice. DHA/EPA deplete cytosolic PDK1 and AKT2 and induce insulin resistance. Akt2 knockout in mice abrogates DHA/EPA-induced PI3K-AKT signaling. Our results identify PUFA's methylene bridge tryptophan acylation, a protein fatty acylation that regulates cell signaling and may underlie multifaceted effects of methylene-bridge-containing PUFAs.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt signaling; DHA/EPA; fatty acylation

Mesh:

Substances:

Year:  2022        PMID: 35294873      PMCID: PMC9396916          DOI: 10.1016/j.celrep.2022.110509

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.995


  76 in total

1.  Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling.

Authors:  Cameron L Noland; Sarah Gierke; Paul D Schnier; Jeremy Murray; Wendy N Sandoval; Meredith Sagolla; Anwesha Dey; Rami N Hannoush; Wayne J Fairbrother; Christian N Cunningham
Journal:  Structure       Date:  2015-12-24       Impact factor: 5.006

2.  n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease.

Authors:  Penny A Asbell; Maureen G Maguire; Maxwell Pistilli; Gui-shuang Ying; Loretta B Szczotka-Flynn; David R Hardten; Meng C Lin; Roni M Shtein
Journal:  N Engl J Med       Date:  2018-04-13       Impact factor: 91.245

3.  Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos.

Authors:  H O Bang; J Dyerberg; A B Nielsen
Journal:  Lancet       Date:  1971-06-05       Impact factor: 79.321

4.  n-3 Polyunsaturated Fatty Acids Reduce Neonatal Hypoxic/Ischemic Brain Injury by Promoting Phosphatidylserine Formation and Akt Signaling.

Authors:  Wenting Zhang; Jia Liu; Xiaoming Hu; Peiying Li; Rehana K Leak; Yanqin Gao; Jun Chen
Journal:  Stroke       Date:  2015-09-15       Impact factor: 7.914

5.  Endogenous Ligand for GPR120, Docosahexaenoic Acid, Exerts Benign Metabolic Effects on the Skeletal Muscles via AMP-activated Protein Kinase Pathway.

Authors:  Nami Kim; Jung Ok Lee; Hye Jeong Lee; Hyung Ip Kim; Joong Kwan Kim; Yong Woo Lee; Soo Kyung Lee; Su Jin Kim; Sun Hwa Park; Hyeon Soo Kim
Journal:  J Biol Chem       Date:  2015-07-01       Impact factor: 5.157

Review 6.  Myristoylation.

Authors:  J A Boutin
Journal:  Cell Signal       Date:  1997-01       Impact factor: 4.315

7.  A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha.

Authors:  H M Horton; D Anderson; P Hernandez; K M Barnhart; J A Norman; S E Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?

Authors:  J Dyerberg; H O Bang; E Stoffersen; S Moncada; J R Vane
Journal:  Lancet       Date:  1978-07-15       Impact factor: 79.321

9.  Tropomodulin3 is a novel Akt2 effector regulating insulin-stimulated GLUT4 exocytosis through cortical actin remodeling.

Authors:  Chun-Yan Lim; Xuezhi Bi; Donghai Wu; Jae Bum Kim; Peter W Gunning; Wanjin Hong; Weiping Han
Journal:  Nat Commun       Date:  2015-01-09       Impact factor: 14.919

10.  Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder.

Authors:  Paul J Sorgi; Edward M Hallowell; Heather L Hutchins; Barry Sears
Journal:  Nutr J       Date:  2007-07-13       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.